Markets are Closed
Company Logo
PODD
Insulet Corporation

Open

Previous Open

High

Previous High

Low

Previous Low

Close

Previous Close

Volume

Previous Volume

Company Profile

Description

Insulet Corp is a medical device company based in Billerica, Massachusetts. The company develops, manufactures and sells OmniPod Insulin Management System, an insulin infusion system for people with insulin-dependent diabetes.

Exchange

Nasdaq Global Select

List Date

May 15, 2007

CEO

Patrick J. Sullivan

Employees

857

Financials

Revenue

738.20M

Earnings

49.10M
620M
451M
282M
114M
-54M
2015
2016
2017
2018

Splits

No splits to date

Dividends

No dividends paid to date

Related News

News post image: Insulet (PODD) Down 7.5% Since Last Earnings Report: Can It Rebound?
Insulet (PODD) Down 7.5% Since Last Earnings Report: Can It Rebound?
Mar 26, 2020 @ 15:30
Insulet (PODD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues....
finance yahoo
News post image: Hedge Funds Were Selling Insulet Corporation (PODD) Before The Coronavirus
Hedge Funds Were Selling Insulet Corporation (PODD) Before The Coronavirus
Mar 17, 2020 @ 19:17
Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted that a US recession is imminent and US stocks will go down by at least 20% in the next 3-6 […]...
finance yahoo
News post image: Insulet’s Omnipod DASH™ System Voted 2020 Product of the Year in Health Systems Category by 40,000 U.S. Consumers
Insulet’s Omnipod DASH™ System Voted 2020 Product of the Year in Health Systems Category by 40,000 U.S. Consumers
Mar 05, 2020 @ 11:00
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® DASH Insulin Management System (Omnipod DASH™ System), announced today that the Company’s Omnipod DASH™ System has been named the 2020 Product of the Year in the Health...
finance yahoo
News post image: Edited Transcript of PODD earnings conference call or presentation 25-Feb-20 9:30pm GMT
Edited Transcript of PODD earnings conference call or presentation 25-Feb-20 9:30pm GMT
Mar 02, 2020 @ 11:06
Q4 2019 Insulet Corp Earnings Call...
finance yahoo
News post image: Insulet Provides Update on Pivotal Study of Omnipod Horizon™
Insulet Provides Update on Pivotal Study of Omnipod Horizon™
Mar 02, 2020 @ 11:00
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, today announced that it plans to pause the pivotal study of the Omnipod Horizon™ Automated Glucose Control System to correct a software anomaly...
finance yahoo
News post image: Here's how local companies are reacting to the coronavirus
Here's how local companies are reacting to the coronavirus
Feb 28, 2020 @ 19:26
While many Massachusetts companies are taking a wait-and-see approach to see if the coronavirus spreads in the Bay State, many are taking proactive measures to protect employees, maintain supply chains or get ready for major delays....
finance yahoo
News post image: Insulet (PODD) Lags Q4 Earnings Estimates
Insulet (PODD) Lags Q4 Earnings Estimates
Feb 25, 2020 @ 22:15
Insulet (PODD) delivered earnings and revenue surprises of -11.11% and 5.87%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?...
finance yahoo
News post image: Diabetes Devices Outlet Tumbles On Mixed Report As Earnings Lag
Diabetes Devices Outlet Tumbles On Mixed Report As Earnings Lag
Feb 25, 2020 @ 21:35
Diabetes treatment player Insulet reported a mixed fourth quarter as adjusted earnings of 8 cents per share lagged expectations, though $209.4 million in sales beat. PODD stock tumbled....
finance yahoo
News post image: Insulet Reports Full Year 2019 Revenue of $738.2 Million, an Increase of 31%, and Fourth Quarter 2019 Revenue of $209.4 Million, an Increase of 27% Year-Over-Year
Insulet Reports Full Year 2019 Revenue of $738.2 Million, an Increase of 31%, and Fourth Quarter 2019 Revenue of $209.4 Million, an Increase of 27% Year-Over-Year
Feb 25, 2020 @ 21:01
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (Omnipod System), today announced financial results for the three months and full year ended December 31, 2019....
finance yahoo
News post image: Insulet to Present at Upcoming Investor Conferences
Insulet to Present at Upcoming Investor Conferences
Feb 24, 2020 @ 13:38
Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® Insulin Management System, today announced that management will present at four upcoming investor conferences (all times below are in Eastern Time):...
finance yahoo
All data provided on Polygon is provided for informational purposes only, and is not intended for trading or investing purposes.
Copyright © 2021, Polygon.io, Inc. All Rights Reserved.
TradingView Lightweight Chart: Copyright (с) 2020 TradingView, Inc. https://www.tradingview.com/